Skip to main content

Changes in the Faecal Flora During Treatment with Metronidazole or Sulfasalazine

  • Chapter
Recent Advances in Crohn’s Disease

Part of the book series: Developments in Gastroenterology ((DIGA,volume 1))

  • 18 Accesses

Abstract

In the search for etiological factors in Crohn’s disease the attention has also been directed to the possibility of a change of the normal bowel microflora. As gut bacteria live in close contact with the bowel mucosa, there is good reason to believe that they play a primary or secondary role in the pathogenesis of Crohn’s disease. Observations such as increased immune response to Escherichia coli and Bacteroides fragilis in patients with Crohn’s disease (1) support this hypothesis. The hypothesis is further supported by the fact that metronidazole, which is highly active against anaerobic bacteria has a good effect in some patients with Crohn’s disease (2,3) and that sulfasalazine which also has an antibacterial effect is effective in active Crohn’s disease (4). However, both these drugs have several other pharmacological effects such as chemotactic, immunosuppressive and anti-inflammatory properties.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Persson S, Danielsson D. (1979) On the Occurrence of Serum Antibodies to Bacteroides fragilis and Serogroups of E. coli in Patients with Crohn’s disease. Scand.J.Infect. Dis. suppl. 19:61–67

    PubMed  Google Scholar 

  2. Ursing B, Kamme C. (1975) Metronidazole for Crohn’s disease. Lancet 1:775–777

    Article  PubMed  CAS  Google Scholar 

  3. Ursing B, Aim T, Bárány F, Bergelin J, Ganrot-Norlin K, Järnerot G, Krause U, Krook A, Rosén A. (1980) Cooperative Crohn’s disease study in Sweden. Manuscript in preparation

    Google Scholar 

  4. Summers RW, Switz DM, Sessions JT Jr., Becktel JM, Best WR, Kern F Jr., Singleton JW. (1979) National Cooperative Crohn’s Disease Study: Results of Drug treatment. Gastroenterol. 77:847–869

    CAS  Google Scholar 

  5. Krook A, Danielsson D, Kjellander J, Jarnerot G. (1979) Changes in the Faecal Flora of Patients with Crohn’s disease during treatment with Metronidazole. A preliminary report. Scand.J.Gastroenterol. 14:705–710

    Article  PubMed  CAS  Google Scholar 

  6. Krook A, Danielsson D, Kjellander J, Järnerot G. (1980) The effect of Metronidazole and Sulfasalazine on the Faecal Flora in Patients with Crohn’s disease. Submitted for publication

    Google Scholar 

  7. Krook A. (1980) Effect of Metronidazole and Sulfasalazine on the normal human faecal flora. Submitted for publication

    Google Scholar 

  8. Holdeman LV, Cato EP, Moore WEC Eds. (1977) Anaerobic Laboratory Manual, 4th Ed. Virginia Polytechnic Institute and University, Blacksburg, Virginia

    Google Scholar 

  9. Krook A, Lindstrom B, Kjellander J, JarnerSt G, Bodin L. (1980) Concentrations of Metronidazole in Plasma and Faeces of Patients with Crohn’s disease and healthy controls. Manuscript in preparation

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Martinus Nijhoff Publishers bv, The Hague

About this chapter

Cite this chapter

Krook, A., Danielsson, D., Järnerot, G., Kjellander, J. (1981). Changes in the Faecal Flora During Treatment with Metronidazole or Sulfasalazine. In: Peña, A.S., Weterman, I.T., Booth, C.C., Strober, W. (eds) Recent Advances in Crohn’s Disease. Developments in Gastroenterology, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8273-4_66

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-8273-4_66

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-8275-8

  • Online ISBN: 978-94-009-8273-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics